Xenon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Xenon Pharmaceuticals has a total shareholder equity of $797.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $835.9M and $38.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$654.02m |
| Equity | US$797.81m |
| Total liabilities | US$38.09m |
| Total assets | US$835.90m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XP0's short term assets ($659.6M) exceed its short term liabilities ($29.7M).
Long Term Liabilities: XP0's short term assets ($659.6M) exceed its long term liabilities ($8.4M).
Debt to Equity History and Analysis
Debt Level: XP0 is debt free.
Reducing Debt: XP0 has no debt compared to 5 years ago when its debt to equity ratio was 20.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XP0 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if XP0 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.